Logo image of Z

ZILLOW GROUP INC - C (Z) Stock Fundamental Analysis

USA - NASDAQ:Z - US98954M2008 - Common Stock

86.74 USD
-3.24 (-3.6%)
Last: 9/19/2025, 8:00:02 PM
86.5108 USD
-0.23 (-0.26%)
After Hours: 9/19/2025, 8:00:02 PM
Fundamental Rating

5

Taking everything into account, Z scores 5 out of 10 in our fundamental rating. Z was compared to 63 industry peers in the Real Estate Management & Development industry. Z has a great financial health rating, but its profitability evaluates not so good. Z is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

Z had positive earnings in the past year.
In the past year Z had a positive cash flow from operations.
Z had negative earnings in each of the past 5 years.
Of the past 5 years Z 4 years had a positive operating cash flow.
Z Yearly Net Income VS EBIT VS OCF VS FCFZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

1.2 Ratios

Looking at the Return On Assets, with a value of -1.14%, Z is in line with its industry, outperforming 49.21% of the companies in the same industry.
Looking at the Return On Equity, with a value of -1.31%, Z is in line with its industry, outperforming 55.56% of the companies in the same industry.
Industry RankSector Rank
ROA -1.14%
ROE -1.31%
ROIC N/A
ROA(3y)-1.95%
ROA(5y)-2.59%
ROE(3y)-2.68%
ROE(5y)-4.27%
ROIC(3y)N/A
ROIC(5y)N/A
Z Yearly ROA, ROE, ROICZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2 -4 -6 -8

1.3 Margins

Z's Gross Margin of 75.75% is amongst the best of the industry. Z outperforms 88.89% of its industry peers.
In the last couple of years the Gross Margin of Z has grown nicely.
Z does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y42.3%
GM growth 5Y9.85%
Z Yearly Profit, Operating, Gross MarginsZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

8

2. Health

2.1 Basic Checks

Z does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for Z has been increased compared to 1 year ago.
Z has more shares outstanding than it did 5 years ago.
The debt/assets ratio for Z has been reduced compared to a year ago.
Z Yearly Shares OutstandingZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
Z Yearly Total Debt VS Total AssetsZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 19.68 indicates that Z is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 19.68, Z belongs to the top of the industry, outperforming 93.65% of the companies in the same industry.
Z has a debt to FCF ratio of 1.07. This is a very positive value and a sign of high solvency as it would only need 1.07 years to pay back of all of its debts.
Z has a better Debt to FCF ratio (1.07) than 84.13% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that Z is not too dependend on debt financing.
Z has a better Debt to Equity ratio (0.05) than 80.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.07
Altman-Z 19.68
ROIC/WACCN/A
WACC9.3%
Z Yearly LT Debt VS Equity VS FCFZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

2.3 Liquidity

A Current Ratio of 3.34 indicates that Z has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.34, Z is in the better half of the industry, outperforming 74.60% of the companies in the same industry.
Z has a Quick Ratio of 3.34. This indicates that Z is financially healthy and has no problem in meeting its short term obligations.
Z has a better Quick ratio (3.34) than 79.37% of its industry peers.
Industry RankSector Rank
Current Ratio 3.34
Quick Ratio 3.34
Z Yearly Current Assets VS Current LiabilitesZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.72% over the past year.
Z shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.31%.
Z shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.00% yearly.
EPS 1Y (TTM)11.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.56%
Revenue 1Y (TTM)15.31%
Revenue growth 3Y-35.01%
Revenue growth 5Y-4%
Sales Q2Q%14.51%

3.2 Future

Z is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.71% yearly.
The Revenue is expected to grow by 15.05% on average over the next years. This is quite good.
EPS Next Y21.54%
EPS Next 2Y29.5%
EPS Next 3Y32.37%
EPS Next 5Y33.71%
Revenue Next Year15.32%
Revenue Next 2Y14.95%
Revenue Next 3Y14.9%
Revenue Next 5Y15.05%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
Z Yearly Revenue VS EstimatesZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
Z Yearly EPS VS EstimatesZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 4

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 60.66, Z can be considered very expensive at the moment.
Based on the Price/Earnings ratio, Z is valued a bit cheaper than the industry average as 65.08% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.38, Z is valued quite expensively.
Based on the Price/Forward Earnings ratio of 37.75, the valuation of Z can be described as expensive.
Z's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. Z is cheaper than 73.02% of the companies in the same industry.
Z is valuated expensively when we compare the Price/Forward Earnings ratio to 22.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 60.66
Fwd PE 37.75
Z Price Earnings VS Forward Price EarningsZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of Z is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, Z is valued a bit cheaper than the industry average as 60.32% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 97.74
EV/EBITDA 152.05
Z Per share dataZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates Z does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as Z's earnings are expected to grow with 32.37% in the coming years.
PEG (NY)2.82
PEG (5Y)N/A
EPS Next 2Y29.5%
EPS Next 3Y32.37%

0

5. Dividend

5.1 Amount

No dividends for Z!.
Industry RankSector Rank
Dividend Yield N/A

ZILLOW GROUP INC - C

NASDAQ:Z (9/19/2025, 8:00:02 PM)

After market: 86.5108 -0.23 (-0.26%)

86.74

-3.24 (-3.6%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners95.52%
Inst Owner Change1.23%
Ins Owners6.74%
Ins Owner Change4.13%
Market Cap21.01B
Analysts72.67
Price Target90.3 (4.1%)
Short Float %8.58%
Short Ratio5.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.6%
Min EPS beat(2)-7.26%
Max EPS beat(2)8.47%
EPS beat(4)2
Avg EPS beat(4)3.07%
Min EPS beat(4)-7.26%
Max EPS beat(4)18.32%
EPS beat(8)6
Avg EPS beat(8)22.01%
EPS beat(12)10
Avg EPS beat(12)78.63%
EPS beat(16)13
Avg EPS beat(16)27.51%
Revenue beat(2)0
Avg Revenue beat(2)-0.54%
Min Revenue beat(2)-0.78%
Max Revenue beat(2)-0.3%
Revenue beat(4)1
Avg Revenue beat(4)0.3%
Min Revenue beat(4)-0.78%
Max Revenue beat(4)2.69%
Revenue beat(8)5
Avg Revenue beat(8)1.46%
Revenue beat(12)9
Avg Revenue beat(12)2.61%
Revenue beat(16)10
Avg Revenue beat(16)-10.95%
PT rev (1m)8.31%
PT rev (3m)10.88%
EPS NQ rev (1m)0.18%
EPS NQ rev (3m)-13.18%
EPS NY rev (1m)-2.91%
EPS NY rev (3m)-2.68%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-0.19%
Revenue NY rev (1m)0.5%
Revenue NY rev (3m)0.5%
Valuation
Industry RankSector Rank
PE 60.66
Fwd PE 37.75
P/S 8.8
P/FCF 97.74
P/OCF 43.42
P/B 4.43
P/tB 12.83
EV/EBITDA 152.05
EPS(TTM)1.43
EY1.65%
EPS(NY)2.3
Fwd EY2.65%
FCF(TTM)0.89
FCFY1.02%
OCF(TTM)2
OCFY2.3%
SpS9.86
BVpS19.59
TBVpS6.76
PEG (NY)2.82
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.14%
ROE -1.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.75%
FCFM 9%
ROA(3y)-1.95%
ROA(5y)-2.59%
ROE(3y)-2.68%
ROE(5y)-4.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y42.3%
GM growth 5Y9.85%
F-Score7
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.07
Debt/EBITDA 1.74
Cap/Depr 101.51%
Cap/Sales 11.26%
Interest Coverage N/A
Cash Conversion 366.67%
Profit Quality N/A
Current Ratio 3.34
Quick Ratio 3.34
Altman-Z 19.68
F-Score7
WACC9.3%
ROIC/WACCN/A
Cap/Depr(3y)73.5%
Cap/Depr(5y)73.95%
Cap/Sales(3y)7.76%
Cap/Sales(5y)5.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.56%
EPS Next Y21.54%
EPS Next 2Y29.5%
EPS Next 3Y32.37%
EPS Next 5Y33.71%
Revenue 1Y (TTM)15.31%
Revenue growth 3Y-35.01%
Revenue growth 5Y-4%
Sales Q2Q%14.51%
Revenue Next Year15.32%
Revenue Next 2Y14.95%
Revenue Next 3Y14.9%
Revenue Next 5Y15.05%
EBIT growth 1Y39.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year430.12%
EBIT Next 3Y96.41%
EBIT Next 5Y60.65%
FCF growth 1Y-25.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.5%
OCF growth 3YN/A
OCF growth 5YN/A